These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 33324595)
1. The Economic Burden of Braae UC; Møller FT; Ibsen R; Ethelberg S; Kjellberg J; Mølbak K Front Public Health; 2020; 8():562957. PubMed ID: 33324595 [No Abstract] [Full Text] [Related]
2. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study. Antunes A; Tricotel A; Wilk A; Dombrowski S; Rinta-Kokko H; Andersson FL; Ghosh S BMC Infect Dis; 2024 May; 24(1):548. PubMed ID: 38822244 [TBL] [Abstract][Full Text] [Related]
3. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland. Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202 [TBL] [Abstract][Full Text] [Related]
4. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis. Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650 [TBL] [Abstract][Full Text] [Related]
5. Costs Associated with the Treatment of Clostridioides Difficile Infections. Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098 [TBL] [Abstract][Full Text] [Related]
6. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016. Mollard S; Lurienne L; Heimann SM; Bandinelli PA J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052 [TBL] [Abstract][Full Text] [Related]
7. Excess length of hospital stay, mortality and cost attributable to Kimura T; Stanhope S; Sugitani T Epidemiol Infect; 2020 Mar; 148():e65. PubMed ID: 32115019 [TBL] [Abstract][Full Text] [Related]
8. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study. Ghosh S; Antunes A; Rinta-Kokko H; Chaparova E; Lay-Flurrie S; Tricotel A; Andersson FL Int J Infect Dis; 2024 May; 142():106967. PubMed ID: 38368927 [TBL] [Abstract][Full Text] [Related]
9. Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study. Bouza E; Cobo J; Rodríguez-Hernández MJ; Salavert M; Horcajada JP; Iribarren JA; Obi E; Lozano V; Maratia S; Cuesta M; Uría E; Limón E Rev Esp Quimioter; 2021 Apr; 34(2):126-135. PubMed ID: 33618513 [TBL] [Abstract][Full Text] [Related]
10. Clostridioides difficile infection, recurrence and the associated healthcare consumption in Sweden between 2006 and 2019: a population-based cohort study. Boven A; Simin J; Andersson FL; Vlieghe E; Callens S; Zeebari Z; Engstrand L; Brusselaers N BMC Infect Dis; 2024 May; 24(1):468. PubMed ID: 38702635 [TBL] [Abstract][Full Text] [Related]
11. The economic burden of Duhalde L; Lurienne L; Wingen-Heimann SM; Guillou L; Buffet R; Bandinelli PA Infect Control Hosp Epidemiol; 2020 Jul; 41(7):813-819. PubMed ID: 32408912 [TBL] [Abstract][Full Text] [Related]
12. Excess burden associated with Clostridioides difficile infection in haematological patients occurring during hospitalization with induction chemotherapy in the USA. Duhalde L; Lurienne L; Wingen-Heimann SM; Guillou L; Buffet R; Bandinelli PA J Hosp Infect; 2020 Apr; 104(4):560-566. PubMed ID: 31870888 [TBL] [Abstract][Full Text] [Related]
13. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries. Yu H; Flaster N; Casanello AL; Curcio D Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727 [TBL] [Abstract][Full Text] [Related]
14. Temporal change of risk factors in hospital-acquired Song J; Cohen B; Zachariah P; Liu J; Larson EL Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1048-1057. PubMed ID: 32468975 [TBL] [Abstract][Full Text] [Related]
15. Characterizing Magro M; Rosenberg J; Epson E Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820 [TBL] [Abstract][Full Text] [Related]
16. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective. Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805 [TBL] [Abstract][Full Text] [Related]
17. Attributable costs and length of stay of hospital-acquired Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884 [TBL] [Abstract][Full Text] [Related]
18. The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission. Wijarnpreecha K; Aby ES; Kim D; Ungprasert P; Cheungpasitporn W; Thongprayoon C; Lukens FJ; Harnois DM; Kröner PT Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):894-898. PubMed ID: 32541243 [TBL] [Abstract][Full Text] [Related]
19. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults. Feuerstadt P; Nelson WW; Drozd EM; Dreyfus J; Dahdal DN; Wong AC; Mohammadi I; Teigland C; Amin A J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection. Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]